...
首页> 外文期刊>Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics >Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
【24h】

Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.

机译:骨髓基质细胞在人类CD8 +调节性T细胞生成中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Fibroblast-like stromal cells exert a strong inhibitory effect on lymphocyte proliferation, both directly by interacting with responding lymphocytes and indirectly by inducing the generation of regulatory T cells. Indeed, upon triggering via the CD3/TCR complex, highly effective CD8(+)regulatory cells (CD8(+)Reg(c)) are generated from cocultures of peripheral blood CD8(+)T cells and bone-marrow-derived stromal cells. When cell-to-cell interactions occur, CD8(+)Reg(c) strongly inhibit lymphocyte proliferation at a ratio of 1:1 to 1:100 between CD8(+)Reg(c) and responding lymphocytes. Phenotypic analysis indicated that CD8(+)Reg(c) are CD25(+)CD28(+) and express low levels of mRNA for Foxp3 but they do not bear CTLA4 and glucocorticoid-induced tumor necrosis factor receptor antigens. Soluble mediators such as interleukin-10, transforming growth factor-beta, and prostaglandin E(2) are not involved in the generation of CD8(+)Reg(c) from CD8(+) precursors or in the immunosuppressive mechanism mediated by CD8(+)Reg(c) on lymphocyte proliferation. Cyclosporin A (CSA) slightly downregulated generation of CD8(+)Reg(c) indicating that only a small fraction of precursors of CD8(+)Reg(c) are sensitive to this immune-suppressive drug. Along this line, treatment of effector CD8(+)Reg(c)with CSA does not affect their immunosuppressive effect, indicating that the molecular mechanism of CD8(+)Reg(c)-mediated regulation is independent of the function of CSA biochemical target molecules.
机译:成纤维样基质细胞直接通过与反应性淋巴细胞相互作用,并通过诱导调节性T细胞的产生而间接地对淋巴细胞增殖产生强大的抑制作用。确实,通过CD3 / TCR复合物触发后,外周血CD8(+)T细胞与骨髓基质细胞共培养产生了高效的CD8(+)调节细胞(CD8(+)Reg(c)) 。当发生细胞间相互作用时,CD8(+)Reg(c)与CD8(+)Reg(c)和响应淋巴细胞之间的比例为1:1至1:100,从而强烈抑制淋巴细胞增殖。表型分析表明,CD8(+)Reg(c)是CD25(+)CD28(+),对于Foxp3表达低水平的mRNA,但它们不携带CTLA4和糖皮质激素诱导的肿瘤坏死因子受体抗原。可溶性介体,例如白介素10,转化生长因子-β和前列腺素E(2)不参与从CD8(+)前体生成CD8(+)Reg(c)或由CD8(+)介导的免疫抑制机制。 +)Reg(c)关于淋巴细胞增殖。环孢菌素A(CSA)稍微下调了CD8(+)Reg(c)的生成,表明CD8(+)Reg(c)的前体中只有一小部分对此免疫抑制药物敏感。沿着这条路线,用CSA处理效应物CD8(+)Reg(c)不会影响其免疫抑制作用,表明CD8(+)Reg(c)介导的调节的分子机制与CSA生化靶标的功能无关分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号